Mitochonic acid 5 (Synonyms: MA-5)
目录号: PL07349 纯度: ≥99%
CAS No. :1354707-41-7
商品编号 规格 价格 会员价 是否有货 数量
PL07349-5mg 5mg ¥2089.00 请登录
PL07349-10mg 10mg ¥3696.00 请登录
PL07349-25mg 25mg ¥7393.00 请登录
PL07349-50mg 50mg ¥13179.00 请登录
PL07349-100mg 100mg ¥22501.00 请登录
PL07349-200mg 200mg 询价 询价
PL07349-500mg 500mg 询价 询价
PL07349-10mM*1mLinDMSO 10mM*1mLinDMSO ¥2298.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
Mitochonic acid 5
中文别名
4-(2,4-二氟苯基)-2-(1H-吲哚-3-基)-4-氧代丁酸
英文名称
Mitochonic acid 5
英文别名
Mitochonic acid 5;4-(2,4-difluorophenyl)-2-(1H-indol-3-yl)-4-oxobutanoic acid;Mitochonic acid 5(MA-5);MA-5; MA 5; MA5;BCP34060;4-(2,4-difluorophenyl)-2-(1H-indol-3-yl)-4-oxo-butanoic acid;4-(2,4-Difluorophenyl)-2-(1H-indole-3-yl)-4-oxobutanoic acid
Cas No.
1354707-41-7
分子式
C18H13F2NO3
分子量
329.30
包装储存
Powder -20°C 3 years;4°C 2 years
产品详情
Mitochonic acid 5 与线粒体结合,并改善肾小管和心肌细胞损伤。Mitochonic acid 5 调节线粒体 ATP 合成。
生物活性
Mitochonic acid 5 binds mitochondria and ameliorates renal tubular and cardiac myocyte damage. Mitochonic acid 5 modulates mitochondrial ATP synthesis.
性状
Solid
IC50 & Target[1][2]
Mitochondrial Metabolism
体外研究(In Vitro)
Mitochonic acid 5 (MA-5) modulates mitochondrial ATP synthesis independently of oxidative phosphorylation and the electron transport chain. Mitochondrial dysfunction causes increased oxidative stress and depletion of ATP, which are involved in the etiology of a variety of renal diseases. Mitochonic acid 5 (MA-5), which is derived from the plant growth hormone indole-3-acetic acid, can protect mitochondrial function by regulating energy metabolism and reducing mitochondrial oxidative stress. To observe the protective role of Mitochonic acid 5 in microglia under inflammatory conditions, TNFα is applied. Subsequently, the MTT assay is used to evaluate cell viability. In response to the TNFα treatment, cell viability significantly decreases. However, this effect is dose-dependently inhibited by Mitochonic acid 5 treatment.
体内研究(In Vivo)
Administration of Mitochonic acid 5 (MA-5) to an ischemia-reperfusion injury model and a cisplatin-induced nephropathy model improved renal function. To examine the tissue-protective effect of Mitochonic acid 5, the oral bioavailability is examined. Oral administration of Mitochonic acid 5 increases the plasma concentration in a dose-response manner at the peak time of 1 hour. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Suzuki T, et al. Mitochonic Acid 5 Binds Mitochondria and Ameliorates Renal Tubular and Cardiac Myocyte Damage. J Am Soc Nephrol. 2016 Jul;27(7):1925-32.
[2]. Lei Q, et al. Mitochonic acid 5 activates the MAPK-ERK-yap signaling pathways to protect mouse microglial BV-2 cells against TNFα-induced apoptosis via increased Bnip3-related mitophagy. Cell Mol Biol Lett. 2018 Apr 5;23:14.
溶解度数据
In Vitro: DMSO : ≥ 106.66 mg/mL (323.90 mM)H2O : < 0.1 mg/mL (insoluble)
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2